Glinta Plus Tablet 10 mg+5 mg is a combination oral antidiabetic medication containing Empagliflozin (10 mg) and Linagliptin (5 mg). This dual-action therapy is designed to manage type 2 diabetes mellitus by targeting multiple mechanisms that regulate blood glucose levels. While Linagliptin enhances insulin secretion and inhibits excessive glucagon production, Empagliflozin promotes the excretion of excess glucose through urine, providing effective glycemic control with a low risk of hypoglycemia.

This combination makes Glinta Plus an ideal choice for patients who require enhanced blood sugar control beyond monotherapy, helping to achieve both fasting and postprandial glucose stability.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Glinta Plus Tablet 10 mg+5 mg is primarily indicated for:

• Type 2 diabetes mellitus – For patients inadequately controlled with diet, exercise, or monotherapy with either Linagliptin or Empagliflozin.

• Combination therapy – Can be used alongside other antidiabetic agents when clinically appropriate.

• Prevention of complications – Effective blood sugar control reduces the risk of long-term complications such as cardiovascular, kidney, and nerve damage.

Mechanism of Action

This combination works through complementary mechanisms:

• Linagliptin (DPP-4 inhibitor): Increases incretin hormone levels, enhancing insulin release after meals and reducing glucagon secretion, improving glucose regulation.

• Empagliflozin (SGLT2 inhibitor): Blocks glucose reabsorption in the kidneys, promoting excretion of excess sugar through urine and reducing blood glucose levels independently of insulin.

Together, they provide comprehensive glycemic control by addressing both insulin-dependent and insulin-independent pathways.

Dosage and Administration

• Recommended dose: One tablet daily, taken at the same time each day, with or without food.

• Administration: Swallow the tablet whole with water; do not crush or chew.

• Monitoring: Regular blood glucose and kidney function tests are advised to ensure effectiveness and safety.

Precautions and Warnings

• Kidney function: Empagliflozin is not recommended in severe renal impairment; monitoring is essential.

• Hypoglycemia risk: Low when used alone, but may increase if combined with sulfonylureas or insulin.

• Dehydration: SGLT2 inhibitors may cause increased urination; maintain adequate hydration.

• Pregnancy and breastfeeding: Use only under medical supervision.

• Drug interactions: Inform your doctor about all medications being taken.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects may include:

• Urinary tract infections or increased urination

• Nasopharyngitis (cold-like symptoms)

• Mild gastrointestinal discomfort

• Headache or dizziness

Serious side effects are rare but require prompt medical attention.

Storage

Store Glinta Plus Tablet 10 mg+5 mg in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.

Conclusion

Glinta Plus Tablet 10 mg+5 mg by SK Pharma is a modern dual-action antidiabetic therapy that combines the benefits of Linagliptin and Empagliflozin for effective blood sugar control in type 2 diabetes. Its complementary mechanisms target both insulin-dependent and insulin-independent pathways, offering comprehensive glycemic management while minimizing the risk of hypoglycemia. Regular monitoring and adherence to therapy ensure safe and effective diabetes management.